Eversept Partners, LP Iradimed Corp Transaction History

Eversept Partners, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$20.6 - $37.15 $362,724 - $654,137	-17,608 Closed	0 $0
Q2 2018 Nov 08, 2023	SELL	$14.15 - $20.75 $473,331 - $694,108	-33,451 Reduced 65.51%	17,608 $365,000
Q2 2018 Aug 14, 2018	SELL	$14.15 - $20.75 $473,331 - $694,108	-33,451 Reduced 65.51%	17,608 $365,000
Q1 2018 Nov 08, 2023	BUY	$13.0 - $15.8 $663,767 - $806,732	51,059 New	51,059 $735 Million
Q4 2017 Nov 08, 2023	BUY	$10.0 - $15.7 $510,590 - $801,626	51,059 New	51,059 $774 Million
Q4 2017 Feb 12, 2018	BUY	$10.0 - $15.7 $510,590 - $801,626	51,059	51,059 $774,000

138

6.77M

6.9K

100

Ticker IRMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,565,100
Market Cap $618M
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.